Showing results (271-280 of 326) with videos related to

Sort By:
Pageof 33
Seminars in Oncology|June 1, 1994
Nonoperative management of non-small cell lung cancer: the current cancer and leukemia group B experienceM R Green, M P Kosty, J J Muscato, et al.
American Journal of Clinical Oncology|October 1, 1992
Intensive etoposide and carboplatin chemotherapy for advanced non-small-cell lung cancer. A phase II trial of the Cancer and Leukemia Group BA P Lyss, M C Perry, M Goutsou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2006
Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902C M Rocha-Lima, J E Herndon, M E Lee, et al.
Cancer|September 1, 1993
Effect of radiologic stage III substage on nonsurgical therapy of non-small cell lung cancerH Kreisman, A Lisbona, L Olson, et al.
The Annals of Thoracic Surgery|July 27, 1999
Lung cancer staging and treatment in multidisciplinary trials: Cancer and Leukemia Group B cooperative group approach. Thoracic Surgeons of CALGBM J Krasna, C E Reed, W C Nugent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
Trimetrexate in malignant mesothelioma: A Cancer and Leukemia Group B Phase II studyN J Vogelzang, L B Weissman, J E Herndon, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 1996
A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: a Cancer and Leukemia Group B studyS L Graziano, F H Valone, J E Herndon, et al.
Seminars in Oncology|September 5, 1998
Combined cisplatin and gemcitabine for non-small cell lung cancer: influence of scheduling on toxicity and drug deliveryR P Abratt, A Sandler, L Crinò, et al.
The Journal of Investigative Dermatology|December 1, 1986
Rapid isolation in large numbers of intact, viable, individual hair follicles from skin: biochemical and ultrastructural characterizationM R Green, C S Clay, W T Gibson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
Intravenous 6-thioguanine or cisplatin, fluorouracil and leucovorin for advanced non-small cell lung cancer: a randomized phase II study of the cancer and leukemia group BE E Vokes, A P Lyss, J E Herndon, et al.
Pageof 33